Order Article Reprints

van Bockel D, Munier CML, Turville S, Badman SG, Walker G, Stella AO, Aggarwal A, Yeang M, Condylios A, Kelleher AD, et al. Evaluation of Commercially Available Viral Transport Medium (VTM) for SARS-CoV-2 Inactivation and Use in Point-of-Care (POC) Testing. Viruses. 2020; 12(11):1208. https://doi.org/10.3390/v12111208

van Bockel, David, C. Mee Ling Munier, Stuart Turville, Steven G. Badman, Gregory Walker, Alberto Ospina Stella, Anupriya Aggarwal, Malinna Yeang, Anna Condylios, Anthony D. Kelleher, and et al. 2020. "Evaluation of Commercially Available Viral Transport Medium (VTM) for SARS-CoV-2 Inactivation and Use in Point-of-Care (POC) Testing" Viruses 12, no. 11: 1208. https://doi.org/10.3390/v12111208

van Bockel, D., Munier, C. M. L., Turville, S., Badman, S. G., Walker, G., Stella, A. O., Aggarwal, A., Yeang, M., Condylios, A., Kelleher, A. D., Applegate, T. L., Vallely, A., Whiley, D., Rawlinson, W., Cunningham, P., Kaldor, J., & Guy, R. (2020). Evaluation of Commercially Available Viral Transport Medium (VTM) for SARS-CoV-2 Inactivation and Use in Point-of-Care (POC) Testing. Viruses, 12(11), 1208. https://doi.org/10.3390/v12111208